For research use only. Not for therapeutic Use.
Bromotubercidin (CAT: I023730) is a reversible inhibitor of RNA synthesis, exerting its action by impeding the process of RNA biosynthesis. This compound’s interaction with the RNA synthesis machinery interferes with the normal progression of transcription, ultimately leading to a reduction in the production of RNA molecules. By targeting this essential cellular process, Bromotubercidin exhibits the ability to modulate gene expression and cellular functions reliant on proper RNA synthesis.
Catalog Number | I023730 |
CAS Number | 21193-80-6 |
Synonyms | 5-Bromotubericidin; NSC103802; NSC 103802; NSC-103802 |
Molecular Formula | C11H13BrN4O4 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 5-bromo-7-beta-D-ribofuranosyl- |
InChI | InChI=1S/C11H13BrN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1 |
InChIKey | ZWTPRQXZXQEKFT-IOSLPCCCSA-N |
SMILES | NC1=C2C(N([C@H]3[C@@H]([C@@H]([C@@H](CO)O3)O)O)C=C2Br)=NC=N1 |
Reference | 1: Brdar B, Reich E. Biochemical and biological properties of 5-bromotubercidin: differential effects on cellular DNA-directed and viral RNA-directed RNA synthesis. Bioorg Med Chem. 2008 Feb 1;16(3):1481-92. doi: 10.1016/j.bmc.2007.10.054. Epub 2007 Oct 22. PMID: 17977728. |